# Patient Care Plan

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Robert Peary (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-EX004-SYN-TD
- Date: 1919-01-13
- Fictional facility: St. Posthumous Health Center
- Fictional author: Thaddeus Lindgren-Okafor, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

## What we are working on

- Tired and breathless doing what used to be easy **S**
- Numb, unsteady feet on top of feet that lost their toes long ago **S**
- He wants to know whether this illness can be treated, and to keep walking and working **S**

## Your goals

- Find the cause of the anemia and the numb feet. Target: 1919-01-21. Recorded outcome: Pernicious anemia confirmed: intrinsic factor and parietal cell antibodies positive, gastrin high. **S**
- Normal hemoglobin and MCV within eight weeks. Target: 1919-03-10. Recorded outcome: Hemoglobin 8.2 to 14.1 g/dL and MCV 118 to 91 fL at eight weeks. **S**
- Recover feeling and balance in the feet and walk without falls. Target: 1919-10-27. Recorded outcome: At fifteen weeks: vibration sense back at the ankles, Romberg negative, Timed Up and Go 10 seconds, no falls; numbness at the ends of the feet persists. **S**
- No foot wound that goes unnoticed. Target: 1919-10-27. Recorded outcome: Daily foot checks; one blister found early and healed in two weeks; podiatry every three months. **S**
- Gastric surveillance planned with him. Target: 1919-03-10. Recorded outcome: Endoscopy without neuroendocrine tumor or dysplasia; repeat in three years by shared decision. **S**

## What we agreed to do

- Diagnosis: blood count with MCV, smear and reticulocytes; vitamin B12, methylmalonic acid, homocysteine and folate; iron studies, LDH and bilirubin; kidney function; TSH and HbA1c; all drawn before the first injection. Guideline: Guidelines for the diagnosis and treatment of cobalamin and folate disorders (2014); Vitamin B12 deficiency in over 16s: diagnosis and management (NG239) (2024); CMID: Clinical Monitoring Intelligence Database, anemia and depression, bipolar, and mood disorders monographs (2026) **S**
- Hematology consultation to confirm the cause and advise on treatment, endoscopy and follow-up. Guideline: Guidelines for the diagnosis and treatment of cobalamin and folate disorders (2014); AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review (2021) **S**
- Treatment started at intake without waiting for the cause, because of neurological signs: cyanocobalamin 1,000 micrograms into the muscle every other day for seven doses; no folic acid alone; no transfusion while he is stable at rest. Guideline: Guidelines for the diagnosis and treatment of cobalamin and folate disorders (2014); Vitamin B12 deficiency in over 16s: diagnosis and management (NG239) (2024) **S**
- Maintenance: weekly injections, taught for self-injection, until neurological improvement levels off, then monthly injections for life; high-dose oral cyanocobalamin (at least 1 mg a day) offered as an alternative; vitamin B12 levels not rechecked routinely once treated. Guideline: Guidelines for the diagnosis and treatment of cobalamin and folate disorders (2014); Vitamin B12 deficiency in over 16s: diagnosis and management (NG239) (2024); CMID: Clinical Monitoring Intelligence Database, anemia and depression, bipolar, and mood disorders monographs (2026) **S**
- Response and safety checks: reticulocytes and potassium in the first week, blood count at about five and eight weeks, methylmalonic acid and homocysteine and iron studies at eight weeks, and symptoms at every visit. Guideline: Guidelines for the diagnosis and treatment of cobalamin and folate disorders (2014); CMID: Clinical Monitoring Intelligence Database, anemia and depression, bipolar, and mood disorders monographs (2026) **S**
- Stomach: upper endoscopy with biopsies by the updated Sydney protocol to confirm autoimmune gastritis and look for neuroendocrine tumors and dysplasia, with a screening colonoscopy at the same session; surveillance interval set from the findings by shared decision; thyroid antibodies checked. Guideline: Vitamin B12 deficiency in over 16s: diagnosis and management (NG239) (2024); AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review (2021); Colorectal Cancer: Screening (2021) **S**
- Nerves and falls: neurological examination (vibration, joint position, reflexes, Romberg, gait, cognition) at each visit; physical therapy for balance and gait; night lights and a clear path at home; a stick outdoors and care on ice. Guideline: CMID: Clinical Monitoring Intelligence Database, anemia and depression, bipolar, and mood disorders monographs (2026); Falls Prevention in Community-Dwelling Older Adults: Interventions (2024) **S**
- Feet: daily skin checks with a mirror, extra-depth shoes with toe fillers and a forefoot rocker sole, no new boots without a fitting, nail and callus care by podiatry every three months, and same-day care for any blister, redness or wound. Guideline: Guidelines on the prevention of foot ulcers in persons with diabetes (IWGDF 2023 update) (2023) **S**
- Mood and cognition: PHQ-9 and MoCA at intake and after treatment, since vitamin B12 deficiency can affect both. Guideline: Vitamin B12 deficiency in over 16s: diagnosis and management (NG239) (2024); CMID: Clinical Monitoring Intelligence Database, anemia and depression, bipolar, and mood disorders monographs (2026); Depression and Suicide Risk in Adults: Screening (2023) **S**

## Follow-up

- 1919-01-13: Establishing primary care for four months of fatigue, breathlessness, pallor, a sore tongue, and numbness and unsteadiness in the feet: blood tests, neurological and foot examination, falls, mood, the first vitamin B12 injection and a hematology consultation **S**
- 1919-01-21: Eight-day review with the reticulocyte response and potassium, seen the same day by hematology: the cause, the injection plan, endoscopy, autoimmune screening and the nerves **S**
- 1919-02-17: Five-week review on the day of upper endoscopy and colonoscopy: blood count, nerves, falls and feet **S**
- 1919-03-10: Eight-week review: blood count, methylmalonic acid, iron studies, the endoscopy biopsies and surveillance **S**
- 1919-03-24: Periodic adult preventive visit **S**
- 1919-04-28: Fifteen-week review: neurological recovery, iron, lifelong maintenance and the plan ahead **S**

This teaching document does not replace care from a qualified clinician.
